Behind Generate's 'feverish' race to raise $400M IPO while window remains open - Fierce Biotech
Generate:Biomedicines is the latest biotech to benefit from a renewed appetite from investors for publicly listed drug developers. | Generate:Biomedicines is the latest biotech to benefit from a renewed appetite from investors for publicly listed drug develop…
Comments